Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management
International Journal of Molecular Sciences · 17.03.2024 · 25 (6) · 3400
DOI: 10.3390/ijms25063400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.03.2024. Verfasst von Joanne Traeger-Synodinos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, National and Kapodistrian University of Athens, St. Sophia's Children's Hospital, 11527 Athens, Greece. Hauptthemen laut MEDLINE: beta-Thalassemia, Hemoglobinopathies. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, AIFA, UE THALAMOSS Project.
Abstract (Originalsprache)
In this short review, we presented and discussed studies on the expression of globin genes in β-thalassemia, focusing on the impact of α-globin gene expression and α-globin modifiers on the phenotype and clinical severity of β-thalassemia. We first discussed the impact of the excess of free α-globin on the phenotype of β-thalassemia. We then reviewed studies focusing on the expression of α-globin-stabilizing protein (AHSP), as a potential strategy of counteracting the effects of the excess of free α-globin on erythroid cells. Alternative processes controlling α-globin excess were also considered, including the activation of autophagy by β-thalassemia erythroid cells. Altogether, the studies reviewed herein are expected to have a potential impact on the management of patients with β-thalassemia and other hemoglobinopathies for which reduction in α-globin excess is clinically beneficial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medical Genetics, National and Kapodistrian University of Athens, St. Sophia's Children's Hospital, 11527 Athens, Greece.
- Department of Life Sciences and Biotechnology, 40124 Ferrara, Italy.
- Center "Chiara Gemmo and Elio Zago" for the Research on Thalassemia, Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.
ORCID-Profile: Joanne Traeger-Synodinos, Christalena Sofocleous, Matteo Zurlo, Alessia Finotti, Roberto Gambari
Förderung
- Wellcome Trust
- AIFA
- UE THALAMOSS Project
- University Research Institute for the Study of Genetic & Malignant Disorders in Childhood, National and Kapodistrian University of Athens, Greece
Zitieren
APA
Traeger-Synodinos, J., Vrettou, C., Sofocleous, C., Zurlo, M., Finotti, A., Gambari, R., & International Hemoglobinopathy Research Network (INHERENT) (2024). Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management. International Journal of Molecular Sciences, 25(6), 3400. https://doi.org/10.3390/ijms25063400
Vancouver
Traeger-Synodinos J, Vrettou C, Sofocleous C, Zurlo M, Finotti A, Gambari R, et al. Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management. International Journal of Molecular Sciences. 2024;25(6):3400. doi:10.3390/ijms25063400
BibTeX
@article{TraegerSynodinos2024,
author = {Traeger-Synodinos, Joanne and Vrettou, Christina and Sofocleous, Christalena and Zurlo, Matteo and Finotti, Alessia and Gambari, Roberto and International Hemoglobinopathy Research Network (INHERENT), International Hemoglobinopathy Research Network (INHERENT)},
title = {Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {6},
pages = {3400},
doi = {10.3390/ijms25063400}
}
EUVIMED